FDA AUTORIZZA IN EMERGENZA L’USO DI TOCILIZUMAB NEI PAZIENTI OSPEDALIZZATI PER COVID-19

COVID19 - EVIDENCE, INTERNATIONAL SNAPSHOTS, MEDICINA INTERNALascia un commento

Coronavirus (COVID-19) Update: FDA Authorizes Drug for Treatment of COVID-19 Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the drug Actemra (tocilizumab) for the treatment of hospitalized adults and pediatric patients (2 years of age and older) who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation,…

LIVING META-ANALYSIS per le terapie ANTI COVID

COVID19 - EVIDENCE, METODOLOGIA, SlideLascia un commento

Abstract Clinical question What is the role of drug interventions in the treatment of patients with covid-19? New recommendation The latest version of this WHO living guidance provides strong recommendations against the use of hydroxychloroquine and lopinavir-ritonavir in patients with covid-19 regardless of disease severity. These recommendations follow the publication of results from the WHO SOLIDARITY trial…

Prevalenza nel mondo reale e conseguenze delle potenziali interazioni farmaco-farmaco nei trattamenti COVID-19 di prima ondata

COVID19 - EVIDENCE, REAL WORLD EVIDENCELascia un commento

Real‐world prevalence and consequences of potential drug‐drug interactions in the first‐wave COVID‐19 treatments Noemí Martínez‐López‐de‐Castro PharmD, PhD ; Marisol Samartín‐Ucha PharmD, PhD ; Adolfo Paradela‐Carreiro PharmD, PhD ; Antonio Pérez‐Landeiro PharmD ; María Teresa Inaraja‐Bobo PharmD, PhD ; Miriam Álvarez‐Payero PharmD ; Inés Castro‐Núñez PharmD ; Nerea García‐Beloso PharmD ; David Robles‐Torres PharmD ; Aida López‐López PharmD ; Sonia González‐Costas PharmD ; Belén Leboreiro‐Enríquez PharmD ; Luis…